Atrial fibrillation (AF) causes important mortality and morbidity on a population-level. So far,
we do not have the means to prevent AF or AF-related complications adequately. Therefore …

Atrial fibrillation (AF) is already an endemic disease, and its prevalence is soaring, due to
both an increasing incidence of the arrhythmia and an age-related increase in its …

Atrial fibrillation (AF) is generally considered a progressive disease, typically evolving from
paroxysmal through persistent to 'permanent'forms, a process attributed to electrical and …

There are exciting new developments in several areas of atrial fibrillation (AF) management
that carry the hope of improving outcomes in AF patients. This paper is an executive …

While management of atrial fibrillation (AF) patients is improved by guideline-conform
application of anticoagulant therapy, rate control, rhythm control, and therapy of …

There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF).
The population with AF is expected to expand considerably and yet, apart from …

Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains
difficult and AF-related complications cause unacceptable morbidity and mortality even on …

ATRIAL FIBRILLATION (AF) IS A COMMON CONTRIBUTOR to cardiovascular morbidity and
mortality. Two generally acceptable strategies exist for long-term AF management, with …

Atrial fibrillation (AF) is the most common sustained heart rhythm disorder and is associated
with substantial morbidity and mortality. Current treatment options for AF have significant …

Atrial fibrillation (AF) is an extremely common clinical problem with an important population
morbidity and mortality burden. The management of AF is complex and fraught with many …